TABLE 5.

. mRS assessment during follow‐up.

mRS Scorea	HHcy group	Non‐HHcy group	p Value
0	6 (14.6%)	27 (32.9%)	.020
1	18 (43.9%)	40 (48.8%)
2	6 (14.6%)	8 (9.8%)
3	7 (17.1%)	6 (7.3%)
4	4 (9.8%)	1 (1.2%)
5	0	0
6	0	0
Total	41	82

mRS: modified Rankin Scale; HHcy: hyperhomocysteinemia.

^aValues are presented as number of patients (%).

†p < .05 versus the non‐HHcy group.